Related Experiment Video

Updated: Sep 23, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Cerebral injury in association with profound iatrogenic hyperglycemia in a neonate

Daryl Efron1, Mike South, Joseph J Volpe

  • 1Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Melbourne, Australia.

European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|July 17, 2003
PubMed

Insights

Severe hyperglycemia poses neurological risks in infants following cerebral ischemia. This first case highlights similar brain injury patterns in newborns as seen in adults, indicating shared vulnerabilities.

Area of Science:

  • Neonatal Neurology
  • Cerebral Ischemia Research
  • Glucose Metabolism in Infants

Background:

  • Established risk of hyperglycemia in adult cerebral ischemia.
  • Limited data on hyperglycemia's impact on infant neurological outcomes.
  • Need to assess neonatal risk factors for brain injury.

Observation:

  • First case report of severe, prolonged hyperglycemia in an infant with cerebral ischemia.
  • Infant sustained a major cerebral lesion.
  • Magnetic resonance imaging revealed bilateral parieto-occipital cortex and subcortical white matter injury.

Findings:

  • Hyperglycemia in infants with cerebral ischemia can cause significant brain lesions.
  • Injury patterns in hyperglycemic infants resemble those in hypoglycemic infants.
  • Suggests similar regional cerebral vulnerability to glucose metabolism alterations in newborns.

Implications:

  • Extends the recognized risk of severe hyperglycemia to the neonatal population.
  • Highlights potential shared vulnerability of posterior brain regions to both hypo- and hyperglycemia.
  • Underscores the importance of glucose control in neonatal neurological injury.

More Related Videos

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...